Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PARK2 Co-Regulated (PACRG) (Middle Region) Peptide

PACRG Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN981300
  • Target See all PACRG products
    PACRG (PARK2 Co-Regulated (PACRG))
    Protein Region
    Middle Region
    Origin
    Human
    Source
    • 1
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-PACRG antibody (Catalog #: ARP52953_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    PACRG (PARK2 Co-Regulated (PACRG))
    Synonyms
    PACRG Peptide, GLUP Peptide, HAK005771 Peptide, PARK2CRG Peptide, RP3-495O10.2 Peptide, zgc:101786 Peptide, RGD1561027 Peptide, 1700008H23Rik Peptide, parkin coregulated Peptide, PARK2 co-regulated Peptide, PARK2 coregulated Peptide, PACRG Peptide, pacrg Peptide, Pacrg Peptide
    Background
    PACRG is a protein that is conserved across metazoans. In vertebrates, this gene is linked in a head-to-head arrangement with the adjacent parkin gene, which is associated with autosomal recessive juvenile Parkinson's disease. These genes are co-regulated in various tissues and they share a bi-directional promoter. Both genes are associated with susceptibility to leprosy. The parkin co-regulated gene protein forms a large molecular complex with chaperones, including heat shock proteins 70 and 90, and chaperonin components. This protein is also a component of Lewy bodies in Parkinson's disease patients, and it suppresses unfolded Pael receptor-induced neuronal cell death.This gene encodes a protein that is conserved across metazoans. In vertebrates, this gene is linked in a head-to-head arrangement with the adjacent parkin gene, which is associated with autosomal recessive juvenile Parkinson's disease. These genes are co-regulated in various tissues and they share a bi-directional promoter. Both genes are associated with susceptibility to leprosy. The parkin co-regulated gene protein forms a large molecular complex with chaperones, including heat shock proteins 70 and 90, and chaperonin components. This protein is also a component of Lewy bodies in Parkinson's disease patients, and it suppresses unfolded Pael receptor-induced neuronal cell death. Multiple transcript variants encoding different isoforms have been found for this gene.

    Alias Symbols: FLJ32724, GLUP, HAK005771, PARK2CRG, RP3-495O10.2

    Protein Size: 296
    Molecular Weight
    33 kDa
    Gene ID
    135138
    NCBI Accession
    NM_152410, NP_689623
    UniProt
    Q96M98
You are here:
Support